-
Company News: Alternative Energy, IPIC Swine Webinars, BI R&D Laboratory
10 May 2024 23:54 GMT
… valuable renewable energy, and benefit immediately with a system … Joseph, Mo., as Boehringer Ingelheim hosted a ribbon cutting … serve animals better.
“Boehringer Ingelheim is not just a global … of US Global Innovation, Boehringer Ingelheim. “This region is a …
-
'The cure is in front of you': The case for stem cell transplants in systemic sclerosis
10 May 2024 19:49 GMT
… ,” he outlined data supporting its benefit.
In the SCOT trial, patients … Cytoxan. He added that the benefits of Cytoxan and mycophenolate mofetil … ;adviser for AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol Myers Squibb …
-
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript
10 May 2024 16:19 GMT
… Medicine in Retinal Health at Boehringer Ingelheim. Victor’s extensive experience is … clinical data, demonstrating the potential benefits of drug delivery with our …
-
Quality of Life Improvements with Biologic Initiation Among Subspecialist-Treated US Patients with Severe Asthma
10 May 2024 03:58 GMT
… to corticosteroids and underestimate the benefits of corticosteroid-sparing agents,30 … patients as well as the benefits of biologic treatment and … boards, consultant, and speaker – AstraZeneca, Boehringer Ingelheim, Genentech, GSK, Novartis, Regeneron, Sanofi …
-
Roger A. Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME
09 May 2024 22:21 GMT
… , eyes with macular leakage may benefit from faricimab compared with other … and financial support from Apellis, Boehringer Ingelheim, Genentech Inc., Regeneron, and others …
-
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
09 May 2024 20:05 GMT
… of Medicine, Retinal Health at Boehringer Ingelheim.
Appointed Tony Gibney to Clearside … ODYSSEY clinical trial, the potential benefits of CLS-AX, Clearside’s …
-
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting
09 May 2024 12:30 GMT
… retinal diseases and partnered with Boehringer Ingelheim, utilizes our SWAP technology … terms of the agreement, Boehringer Ingelheim received an exclusive, worldwide … benefits of such product candidate), and the Company’s partnership with Boehringer Ingelheim …
-
Multi-Disciplinary Expert Perspective on the Management of Type 2 Inflammation-Driven Severe CRSwNP: A Brief Overview of Pathophysiology and Recent Clinical Insights
09 May 2024 08:47 GMT
… strategy for achieving therapeutic benefits in this difficult- … reimbursement policies.
The benefit of a multi-disciplinary … for targeted agents will benefit patient outcomes. Surgery … from ALK, Astra Zeneca, Boehringer Ingelheim, Chiesi, GSK, Menarini, …
-
A year on, Teva CEO Richard Francis celebrates progress in 'Pivot to Growth' plan
08 May 2024 23:53 GMT
… other Humira biosim players like Boehringer Ingelheim.
Following lackluster sales of its … the fact that many pharmacy benefit managers (PBMs) have kept AbbVie …
-
Pfizer Reaches Settlement Agreement On 10,000 Lawsuits Linking Zantac Medication To Cancer
08 May 2024 22:17 GMT
… its kind as patients reported benefits for conditions such as acid … against GSK, Pfizer, Sanofi, and Boehringer Ingelheim.
In April, Sanofi reached an … the suit against GSK and Boehringer Ingelheim.
Stay informed! Receive breaking news …